SLRX

Salarius Pharmaceuticals, Inc.

Latest Form 4:Sale$17byHANISH ARNOLD C (Director) · filed Jan 2, 2026

Salarius Pharmaceuticals, Inc. (SLRX) has 3 SEC Form 4 filings (4 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jan 2, 2026.

  • Industry:Biotechnology
  • CEO:Frederick E. Pierce
  • Employees:2
  • HQ:Houston, TX, US
  • IPO:2015-01-29

Insider Buying

$20K

reported purchases (SEC code P)

Insider Selling

$17

reported sales (SEC code S)

Unique Insiders

2

in the rolling window

Source
Sale$17Jan 2SEC ↗
HANISH ARNOLD CFirst filing
Purchase$4KNov 24SEC ↗
Rosenblum Mark JFirst filing
Purchase$16KNov 20SEC ↗